▶ 調査レポート

世界のボツリヌス毒素市場

• 英文タイトル:Market Study on Botulinum Toxin: Application to Increase for Therapeutic & Aesthetic Purposes

Persistence Market Researchが調査・発行した産業分析レポートです。世界のボツリヌス毒素市場 / Market Study on Botulinum Toxin: Application to Increase for Therapeutic & Aesthetic Purposes / MRC2202A019資料のイメージです。• レポートコード:MRC2202A019
• 出版社/出版日:Persistence Market Research / 2021年12月13日
• レポート形態:英文、PDF、216ページ
• 納品方法:Eメール
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥632,100 (USD4,900)▷ お問い合わせ
  Site Licence¥980,400 (USD7,600)▷ お問い合わせ
  Enterprisewide¥1,367,400 (USD10,600)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
Persistence Market Research社の本調査レポートでは、世界のボツリヌス毒素市場について調査・分析し、エグゼクティブサマリー、市場概要、主要市場動向、主要成功要因、市場背景、新型コロナウイルス感染症の危機分析、製品別(タイプA、タイプB)分析、用途別(化粧品、治療薬)分析、エンドユーザー別(病院、専門クリニック、スパ&ビューティークリニック)分析、地域別分析、市場構造分析、競争分析、仮定、調査手法など、以下の構成でまとめております。
・エグゼクティブサマリー
・市場概要
・主要市場動向
・主要成功要因
・市場背景
・新型コロナウイルス感染症の危機分析
・世界のボツリヌス毒素市場規模:製品別(タイプA、タイプB)
・世界のボツリヌス毒素市場規模:用途別(化粧品、治療薬)
・世界のボツリヌス毒素市場規模:エンドユーザー別(病院、専門クリニック、スパ&ビューティークリニック)
・世界のボツリヌス毒素市場規模:地域別
・市場構造分析
・競争分析
・仮定
・調査手法

Botulinum Toxin Market – Scope of Report

The latest publication by Persistence Market Research on the global botulinum toxin market evaluates the opportunities and current market landscape and provides detailed analysis and updates about corresponding sections affecting the market. The study offers detailed insights on current market dynamics, which include the drivers, restraints, trends, and opportunities in the market. The principal aim of the market study is to present exclusive information about how the market will perform during the forecast period of 2021-2031.

Important indicators for the successful growth of the market are presented in this comprehensive report, which includes a Year-on-Year (Y-o-Y) growth analysis of the market, and compounded annual growth rate (CAGR), which are described exhaustively in Persistence Market Research’s study. This research study can support readers to know the demand for botulinum toxin products and the quantitative development opportunities during the study period.

The research is beneficial for shareholders in the landscape, including investors, manufacturers, service providers, distributors, and suppliers, and can help them in developing suitable business strategies to flourish in the botulinum toxin market. Insights and information presented in this Persistence Market Research study can be leveraged by shareholders in the botulinum toxin market, industry experts, investors, researchers, and reporters, as well as business enthusiasts.

Market statistics, as well as information linked to the macro- as well as micro-economic variables affecting the business scenario in the botulinum toxin market, are also included in the current study. Depending on potential developments in the market, substantive insights are also encountered in this report. Additionally, by the data submitted in this report, minor companies and new entrants in the industry can be aided in making suitable company choices to achieve traction in the market.

Key Market Segments

Persistence Market Research’s study on the botulinum toxin market offers information divided into four important segments – product, application, end user, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

Product
Type A
Type B

Application
Cosmetics
Crow’s Feet
Forehead Lines
Frown Lines/Glabellar
Square Jaw/Masseter
Others

Therapeutic
Chronic Migraine
Muscle Spasm
Over Reactive Bladder
Hyperhidrosis
Others

End User
Hospitals
Specialty Clinics
Spa & Beauty Clinics

Region
North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East & Africa

Key Questions Answered in Report

Which regions will continue to remain the most profitable markets for botulinum toxin over the coming years?
How will changing trends impact the market?
How has the COVID-19 crisis impacted market growth?
How can market players capture the low-hanging opportunities in developed regions?
What are the strategies of stakeholders in the market to shape their position in this landscape?
What are the restraining factors that investors need to be aware of and might tackle while investing in the market?
What are the developmental trends that will impact the market?
How can companies in the botulinum toxin market avail themselves the growth opportunities in developed and emerging sectors?
Research Methodology

In Persistence Market Research’s study, a unique research methodology is utilized to conduct extensive research on the growth of the botulinum toxin market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts to ensure the accuracy and reliability of the conclusions.

Secondary resources referred to by analysts during the production of the market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.

Comprehensive information acquired from primary and secondary resources acts as validation from companies in the market, and makes Persistence Market Research’s projections on the growth prospects of the botulinum toxin market are more accurate and reliable.

レポート目次

1. Executive Summary

1.1. Global Market Outlook

1.2. Demand Side Trends

1.3. Supply Side Trends

1.4. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

2.3. Inclusion and Exclusions

3. Key Market Trends

3.1. Key Trends Impacting the Market

3.2. Method Innovation / Development Trends

4. Key Success Factors

4.1. Global Treatment Adoption Pattern

4.2. Key Regulations

4.3. Reimbursement Scenario

4.4. Product Approvals

4.5. Key Promotional Strategies of Manufacturers

5. Market Background

5.1. Macro-Economic Factors

5.1.1. Global GDP Growth Outlook

5.1.2. Global Healthcare Expenditure Outlook

5.2. Forecast Factors – Relevance & Impact

5.2.1. Rising Incidence of migraine.

5.2.2. Widespread adoption of Botulinum Toxin across regions.

5.2.3. Growing popularity of Minimally Invasive Surgery.

5.2.4. Increased disposable income.

5.2.5. Increased healthcare expenditure.

5.2.6. Product adoption in emerging countries.

5.2.7. Increased demand for cosmetic procedures

5.2.8. Growing awareness about beauty and appearances.

5.2.9. Average cost of Botulinum Toxin/Unit

5.3. Market Dynamics

5.3.1. Drivers

5.3.2. Restraints

5.3.3. Opportunity Analysis

6. COVID19 Crisis Analysis

6.1. Current COVID19 Probable Future Impact

6.2. Current GDP Projection and Probable Impact

6.3. Current Economic Projection as compared to 2008 Economic analysis

6.4. COVID19 and Impact Analysis

6.4.1. Revenue By Product

6.4.2. Revenue By Application

6.4.3. Revenue By End-User

6.4.4. Revenue By Country

6.5. 2020 Market Scenario

7. Global Botulinum Toxin Market Value (US$ Mn) Analysis 2016-2020 and Forecast, 2021–2031

7.1. Historical Market Value (US$ Mn) Analysis, 2016-2020

7.2. Current and Future Market Value (US$ Mn) Projections, 2021–2031

7.2.1. Y-o-Y Growth Trend Analysis

7.2.2. Absolute $ Opportunity Analysis

8. Global Botulinum Toxin Market Analysis 2016-2020 and Forecast 2021–2031, By Product

8.1. Introduction / Key Findings

8.2. Historical Market Size (US$ Mn) By Product, 2016-2020

8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product, 2021–2031

8.3.1. Type A

8.3.2. Type B

8.4. Market Attractiveness Analysis By Product

9. Global Botulinum Toxin Market Analysis 2016-2020 and Forecast 2021–2031, By Application

9.1. Introduction / Key Findings

9.2. Historical Market Size (US$ Mn) By Application, 2016-2020

9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application, 2021–2031

9.3.1. Cosmetics

9.3.1.1. Crow’s Feet

9.3.1.2. Forehead Lines

9.3.1.3. Frown Lines/Glabellar

9.3.1.4. Square Jaw/Masseter

9.3.1.5. Others

9.3.2. Therapeutic

9.3.2.1. Chronic Migraine

9.3.2.2. Muscle Spasm

9.3.2.3. Over reactive Bladder

9.3.2.4. Hyperhidrosis

9.3.2.5. Others

9.4. Market Attractiveness Analysis By Application

10. Global Botulinum Toxin Market Analysis 2016-2020 and Forecast 2021–2031, By End-User

10.1. Introduction / Key Findings

10.2. Historical Market Size (US$ Mn) By End-User, 2016-2020

10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End-User, 2021–2031

10.3.1. Hospitals

10.3.2. Specialty Clinics

10.3.3. Spa & Beauty Clinic

10.4. Market Attractiveness Analysis By End-User

11. Global Botulinum Toxin Market Analysis 2016-2020 and Forecast 2021–2031, by Region

11.1. Introduction

11.2. Historical Market Size (US$ Mn) Analysis By Region, 2016 – 2020

11.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2021 – 2031

11.3.1. North America

11.3.2. Latin America

11.3.3. Europe

11.3.4. East Asia

11.3.5. South Asia

11.3.6. Oceania

11.3.7. Middle East and Africa (MEA)

11.4. Market Attractiveness Analysis By Region

12. North America Botulinum Toxin Market Analysis 2016-2020 and Forecast 2021–2031

12.1. Introduction

12.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2016-2020

12.3. Current and Future Market Size (US$ Mn) Analysis Forecast By Market Taxonomy, 2021–2031

12.3.1. By Country

12.3.1.1. U.S.

12.3.1.2. Canada

12.3.2. By Product

12.3.3. By Application

12.3.4. By End-User

12.4. Market Attractiveness Analysis

12.5. Key Market Participants – Intensity Mapping

12.6. Drivers and Restraints – Impact Analysis

13. Latin America Botulinum Toxin Market Analysis 2016-2020 and Forecast 2021–2031

13.1. Introduction

13.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014 – 2018

13.3. Current and Future Market Size (US$ Mn) Analysis Forecast By Market Taxonomy, 2021–2031

13.3.1. By Country

13.3.1.1. Brazil

13.3.1.2. Mexico

13.3.1.3. Argentina

13.3.1.4. Rest of Latin America

13.3.2. By Product

13.3.3. By Application

13.3.4. By End-User

13.4. Market Attractiveness Analysis

13.5. Key Market Participants – Intensity Mapping

13.6. Drivers and Restraints – Impact Analysis

14. Europe Botulinum Toxin Market Analysis 2016-2020 and Forecast 2021–2031

14.1. Introduction

14.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2016-2020

14.3. Current and Future Market Size (US$ Mn) Analysis Forecast By Market Taxonomy, 2021–2031

14.3.1. By Country

14.3.1.1. Germany

14.3.1.2. Italy

14.3.1.3. France

14.3.1.4. U.K.

14.3.1.5. Spain

14.3.1.6. BENELUX

14.3.1.7. Russia

14.3.1.8. Rest of Europe

14.3.2. By Product

14.3.3. By Application

14.3.4. By End-User

14.4. Market Attractiveness Analysis

14.5. Key Market Participants – Intensity Mapping

14.6. Drivers and Restraints – Impact Analysis

15. South Asia Botulinum Toxin Market Analysis 2016-2020 and Forecast 2021–2031

15.1. Introduction

15.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2016-2020

15.3. Current and Future Market Size (US$ Mn) Analysis By Market Taxonomy, 2021–2031

15.3.1. By Country

15.3.1.1. India

15.3.1.2. Thailand

15.3.1.3. Indonesia

15.3.1.4. Malaysia

15.3.1.5. Rest of South Asia

15.3.2. By Product

15.3.3. By Application

15.3.4. By End-User

15.4. Market Attractiveness Analysis

15.5. Key Market Participants – Intensity Mapping

15.6. Drivers and Restraints – Impact Analysis

16. East Asia Botulinum Toxin Market Analysis 2016-2020 and Forecast 2021–2031

16.1. Introduction

16.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2016-2020

16.3. Current and Future Market Size (US$ Mn) Analysis By Market Taxonomy, 2021–2031

16.3.1. By Country

16.3.1.1. China

16.3.1.2. Japan

16.3.1.3. South Korea

16.3.2. By Product

16.3.3. By Application

16.3.4. By End-User

16.4. Market Attractiveness Analysis

16.5. Key Market Participants – Intensity Mapping

16.6. Drivers and Restraints – Impact Analysis

17. Oceania Botulinum Toxin Market Analysis 2016-2020 and Forecast 2021–2031

17.1. Introduction

17.2. Historical Market Size (US$ Mn Analysis By Market Taxonomy, 2016-2020

17.3. Current and Future Market Size (US$ Mn) Analysis By Market Taxonomy, 2021–2031

17.3.1. By Country

17.3.1.1. Australia

17.3.1.2. New Zealand

17.3.2. By Product

17.3.3. By Application

17.3.4. By End-User

17.4. Market Attractiveness Analysis

17.5. Key Market Participants – Intensity Mapping

17.6. Drivers and Restraints – Impact Analysis

18. Middle East and Africa Botulinum Toxin Market Analysis 2016-2020 and Forecast 2021–2031

18.1. Introduction

18.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2016-2020

18.3. Current and Future Market Size (US$ Mn) Analysis By Market Taxonomy, 2021–2031

18.3.1. By Country

18.3.1.1. GCC Countries

18.3.1.2. Turkey

18.3.1.3. South Africa

18.3.1.4. Rest of Middle East and Africa

18.3.2. By Product

18.3.3. By Application

18.3.4. By End-User

18.4. Market Attractiveness Analysis

18.5. Key Market Participants – Intensity Mapping

18.6. Drivers and Restraints – Impact Analysis

19. Country Level Botulinum Toxin Market Analysis 2016-2020 and Forecast 2021–2031

19.1. Introduction

19.1.1. Market Value Proportion Analysis, By Country

19.1.2. Global VS. Country Growth Comparison

19.1.3. Pricing Analysis, By Country

19.2. U.S. Botulinum Toxin Market Analysis

19.2.1. By Product

19.2.2. By Application

19.2.3. By End-User

19.3. Canada Botulinum Toxin Market Analysis

19.3.1. By Product

19.3.2. By Application

19.3.3. By End-User

19.4. Brazil Botulinum Toxin Market Analysis

19.4.1. By Product

19.4.2. By Application

19.4.3. By End-User

19.5. Mexico Botulinum Toxin Market Analysis

19.5.1. By Product

19.5.2. By Application

19.5.3. By End-User

19.6. Argentina Botulinum Toxin Market Analysis

19.6.1. By Product

19.6.2. By Application

19.6.3. By End-User

19.7. U.K. Botulinum Toxin Market Analysis

19.7.1. By Product

19.7.2. By Application

19.7.3. By End-User

19.8. Germany Botulinum Toxin Market Analysis

19.8.1. By Product

19.8.2. By Application

19.8.3. By End-User

19.9. France Botulinum Toxin Market Analysis

19.9.1. By Product

19.9.2. By Application

19.9.3. By End-User

19.10. Italy Botulinum Toxin Market Analysis

19.10.1. By Product

19.10.2. By Application

19.10.3. By End-User

19.11. Spain Botulinum Toxin Market Analysis

19.11.1. By Product

19.11.2. By Application

19.11.3. By End-User

19.12. BENELUX Botulinum Toxin Market Analysis

19.12.1. By Product

19.12.2. By Application

19.12.3. By End-User

19.13. Russia Botulinum Toxin Market Analysis

19.13.1. By Product

19.13.2. By Application

19.13.3. By End-User

19.14. Japan Botulinum Toxin Market Analysis

19.14.1. By Product

19.14.2. By Application

19.14.3. By End-User

19.15. China Botulinum Toxin Market Analysis

19.15.1. By Product

19.15.2. By Application

19.15.3. By End-User

19.16. South Korea Botulinum Toxin Market Analysis

19.16.1. By Product

19.16.2. By Application

19.16.3. By End-User

19.17. India Botulinum Toxin Market Analysis

19.17.1. By Product

19.17.2. By Application

19.17.3. By End-User

19.18. ASEAN Botulinum Toxin Market Analysis

19.18.1. By Product

19.18.2. By Application

19.18.3. By End-User

19.19. Australia Botulinum Toxin Market Analysis

19.19.1. By Product

19.19.2. By Application

19.19.3. By End-User

19.20. New Zealand Botulinum Toxin Market Analysis

19.20.1. By Product

19.20.2. By Application

19.20.3. By End-User

19.21. GCC Countries Botulinum Toxin Market Analysis

19.21.1. By Product

19.21.2. By Application

19.21.3. By End-User

19.22. Turkey Botulinum Toxin Market Analysis

19.22.1. By Product

19.22.2. By Application

19.22.3. By End-User

19.23. South Africa Botulinum Toxin Market Analysis

19.23.1. By Product

19.23.2. By Application

19.23.3. By End-User

20. Market Structure Analysis

20.1. Market Analysis by Tier of Companies

20.2. Market Concentration

20.3. Market Share Analysis of Top Players

20.4. Market Presence Analysis

20.4.1.1. Regional footprint of Players

20.4.1.2. Method foot print by Players

20.4.1.3. Channel Foot Print by Players

21. Competition Analysis

21.1. Competition Dashboard

21.2. Competition Benchmarking

21.3. Competition Deep Dive

21.3.1. Allergan PLC

21.3.1.1. Overview

21.3.1.2. Product Portfolio

21.3.1.3. Profitability by Market Segments (Product/Application/Region)

21.3.1.4. Sales Footprint

21.3.1.5. Strategy Overview

21.3.1.5.1. Marketing Strategy

21.3.1.5.2. Product Strategy

21.3.1.5.3. Channel Strategy

21.3.2. U.S. WorldMeds

21.3.2.1. Overview

21.3.2.2. Product Portfolio

21.3.2.3. Profitability by Market Segments (Product/Application/Region)

21.3.2.4. Sales Footprint

21.3.2.5. Strategy Overview

21.3.2.5.1. Marketing Strategy

21.3.2.5.2. Product Strategy

21.3.2.5.3. Channel Strategy

21.3.3. Hugh Source (International) Ltd.

21.3.3.1. Overview

21.3.3.2. Product Portfolio

21.3.3.3. Profitability by Market Segments (Product/Application/Region)

21.3.3.4. Sales Footprint

21.3.3.5. Strategy Overview

21.3.3.5.1. Marketing Strategy

21.3.3.5.2. Product Strategy

21.3.3.5.3. Channel Strategy

21.3.4. Galderma laboratories.

21.3.4.1. Overview

21.3.4.2. Product Portfolio

21.3.4.3. Profitability by Market Segments (Product/Application/Region)

21.3.4.4. Sales Footprint

21.3.4.5. Strategy Overview

21.3.4.5.1. Marketing Strategy

21.3.4.5.2. Product Strategy

21.3.4.5.3. Channel Strategy

21.3.5. Revance Therapeutics, Inc.

21.3.5.1. Overview

21.3.5.2. Product Portfolio

21.3.5.3. Profitability by Market Segments (Product/Application/Region)

21.3.5.4. Sales Footprint

21.3.5.5. Strategy Overview

21.3.5.5.1. Marketing Strategy

21.3.5.5.2. Product Strategy

21.3.5.5.3. Channel Strategy

21.3.6. Ipsen Pharma

21.3.6.1. Overview

21.3.6.2. Product Portfolio

21.3.6.3. Profitability by Market Segments (Product/Application/Region)

21.3.6.4. Sales Footprint

21.3.6.5. Strategy Overview

21.3.6.5.1. Marketing Strategy

21.3.6.5.2. Product Strategy

21.3.6.5.3. Channel Strategy

21.3.7. Merz Pharma GmbH & Co. KGaA

21.3.7.1. Overview

21.3.7.2. Product Portfolio

21.3.7.3. Profitability by Market Segments (Product/Application/Region)

21.3.7.4. Sales Footprint

21.3.7.5. Strategy Overview

21.3.7.5.1. Marketing Strategy

21.3.7.5.2. Product Strategy

21.3.7.5.3. Channel Strategy

21.3.8. Daewoong Pharmaceuticals Co.,Ltd.

21.3.8.1. Overview

21.3.8.2. Product Portfolio

21.3.8.3. Profitability by Market Segments (Product/Application/Region)

21.3.8.4. Sales Footprint

21.3.8.5. Strategy Overview

21.3.8.5.1. Marketing Strategy

21.3.8.5.2. Product Strategy

21.3.8.5.3. Channel Strategy

21.3.9. HUGEL Pharma

21.3.9.1. Overview

21.3.9.2. Product Portfolio

21.3.9.3. Profitability by Market Segments (Product/Application/Region)

21.3.9.4. Sales Footprint

21.3.9.5. Strategy Overview

21.3.9.5.1. Marketing Strategy

21.3.9.5.2. Product Strategy

21.3.9.5.3. Channel Strategy

21.3.10. Medy-Tox Inc

21.3.10.1. Overview

21.3.10.2. Product Portfolio

21.3.10.3. Profitability by Market Segments (Product/Application/Region)

21.3.10.4. Sales Footprint

21.3.10.5. Strategy Overview

21.3.10.5.1. Marketing Strategy

21.3.10.5.2. Product Strategy

21.3.10.5.3. Channel Strategy

21.3.11. Lanzhou Institute of Biological Products Co., Ltd

21.3.11.1. Overview

21.3.11.2. Product Portfolio

21.3.11.3. Profitability by Market Segments (Product/Application/Region)

21.3.11.4. Sales Footprint

21.3.11.5. Strategy Overview

21.3.11.5.1. Marketing Strategy

21.3.11.5.2. Product Strategy

21.3.11.5.3. Channel Strategy

21.3.12. Teijin Pharma Ltd

21.3.12.1. Overview

21.3.12.2. Product Portfolio

21.3.12.3. Profitability by Market Segments (Product/Application/Region)

21.3.12.4. Sales Footprint

21.3.12.5. Strategy Overview

21.3.12.5.1. Marketing Strategy

21.3.12.5.2. Product Strategy

21.3.12.5.3. Channel Strategy

22. Assumptions and Acronyms Used

23. Research Methodology

Table 01: Global Botulinum Toxin Market Value (US$ Mn) by Region, 2016–2031

Table 02: Global Botulinum Toxin Market Value (US$ Mn) By Product, 2016–2031

Table 03: Global Botulinum Toxin Market Value (US$ Mn) By Application, 2016–2031

Table 04: Global Botulinum Toxin Market Value (US$ Mn) By End-User, 2016–2031

Table 05: North America Botulinum Toxin Market Value (US$ Mn) by Country, 2016–2031

Table 06: North America Botulinum Toxin Market Value (US$ Mn) By Product, 2016–2031

Table 07: North America Botulinum Toxin Market Value (US$ Mn) By Application, 2016–2031

Table 08: North America Botulinum Toxin Market Value (US$ Mn) By End-User, 2016–2031

Table 09: Latin America Botulinum Toxin Market Value (US$ Mn) by Country, 2016–2031

Table 10: Latin America Botulinum Toxin Market Value (US$ Mn) By Product, 2016–2031

Table 11: Latin America Botulinum Toxin Market Value (US$ Mn) By Application, 2016–2031

Table 12: Latin America Botulinum Toxin Market Value (US$ Mn) By End-User, 2016–2031

Table 13: Europe Botulinum Toxin Market Value (US$ Mn) by Country, 2016–2031

Table 14: Europe Botulinum Toxin Market Value (US$ Mn) By Product, 2016–2031

Table 15: Europe Botulinum Toxin Market Value (US$ Mn) By Application, 2016–2031

Table 16: Europe Botulinum Toxin Market Value (US$ Mn) By End-User, 2016–2031

Table 17: East Asia Botulinum Toxin Market Value (US$ Mn) by Country, 2016–2031

Table 18: East Asia Botulinum Toxin Market Value (US$ Mn) By Product, 2016–2031

Table 19: East Asia Botulinum Toxin Market Value (US$ Mn) By Application, 2016–2031

Table 20: East Asia Botulinum Toxin Market Value (US$ Mn) By End-User, 2016–2031

Table 21: South Asia Botulinum Toxin Market Value (US$ Mn) by Country, 2016–2031

Table 22: South Asia Botulinum Toxin Market Value (US$ Mn) By Product, 2016–2031

Table 23: South Asia Botulinum Toxin Market Value (US$ Mn) By Application, 2016–2031

Table 24: South Asia Botulinum Toxin Market Value (US$ Mn) By End-User, 2016–2031

Table 25: Oceania Botulinum Toxin Market Value (US$ Mn) by Country, 2016–2031

Table 26: Oceania Botulinum Toxin Market Value (US$ Mn) By Product, 2016–2031

Table 27: Oceania Botulinum Toxin Market Value (US$ Mn) By Application, 2016–2031

Table 28: Oceania Botulinum Toxin Market Value (US$ Mn) By End-User, 2016–2031

Table 29: MEA Botulinum Toxin Market Value (US$ Mn) by Country, 2016–2031

Table 30: MEA Botulinum Toxin Market Value (US$ Mn) By Product, 2016–2031

Table 31: MEA Botulinum Toxin Market Value (US$ Mn) By Application, 2016–2031

Table 32: MEA Botulinum Toxin Market Value (US$ Mn) By End-User, 2016–2031